Christopher Yancey, MD
NPI 1346217783 · Obstetrics & Gynecology Physician · Longview, TX
Enrolled with Medicare as Practitioner - Obstetrics/Gynecology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1346217783
- Entity type
- Individual
- Primary specialty
- Obstetrics & Gynecology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- J0381 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
562 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Colorectal Cancer Screening; Fecal Occult Blood Test, Immunoassay, 1-3 SimultaneousG0328 | 76 | $18 |
| Screening 3d Breast Mammography77063 | 65 | $23 |
| Screening Mammography77067 | 65 | $89 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 63 | $124 |
| Pap Test, Manual Screening88142 | 39 | $19 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 35 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 10 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Estradiol | 74 | 25 |
| Alendronate Sodium | 43 | 15 |
| Metronidazole | 35 | 18 |
| Valacyclovir Hclbrand: Valacyclovir | 27 | — |
| Progesterone, Micronizedbrand: Progesterone | 26 | — |
| Clotrimazole/Betamethasone Dipbrand: Clotrimazole-Betamethasone | 24 | 16 |
| Fluconazole | 22 | 17 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$201 across 7 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-03-03
- Last updated
- 2025-10-02
- Certified
- 2025-10-02
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.